Apollo Endosurgery, Inc. reiterated revenue guidance for the fiscal year 2022. For the year, the company reiterated revenue guidance to be in the range of $73 million to $75 million, inclusive of up to $3 million in foreign currency headwinds. The Company continues to monitor the potential and uncertain impact of adverse economic conditions in the U.S. and OUS.

Continued or sustained COVID-19 pandemic, inflationary or recessionary pressures could impact the Company's ability to achieve these financial projections.